Prostate Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Prostate Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-24Clinical Trial Results: A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating talazoparib in combination with temozolomide in prostate cancer has been terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2026-08-14Clinical Trial Update: Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer [Phase 3]
Phase 3 clinical trial update for Copper-64 PSMA I&T PET imaging in men with newly diagnosed prostate cancer; study status is active not rec…
-
CLINICAL_TRIALS trial_result · 2026-07-20Clinical Trial Results: Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer [Phase 2]
Phase 2 clinical trial results of flibanserin in men undergoing androgen suppression for prostate cancer have been completed.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer [Phase 2]
Phase 2 trial evaluating external beam radiotherapy and high-dose-rate brachytherapy for unfavorable-intermediate, high, and very high-risk …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: High-Risk prostatE Cancer radiatiOn Versus surgERy
A clinical trial in the Netherlands is recruiting to compare radiotherapy versus surgery for high-risk prostate cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial [Phase 2]
Phase 2 placebo-controlled trial evaluating Urolithin A supplementation in men with prostate cancer undergoing radical prostatectomy (URO-PR…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating sequencing abemaciclib before 177Lu-PSMA-617 for metastatic castration-resistant prostate cancer, w…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study [Phase 2]
A Phase 2 clinical trial update evaluating the addition of Relugolix to standard radiation therapy for advanced, oligometastatic prostate ca…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes [Phase 2]
A Phase 2 clinical trial evaluating intermittent fasting with a fasting-mimicking diet to improve prostate cancer control and metabolic outc…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Clinical Trial of Green Tea Catechins in Men on Active Surveillance [Phase 2]
A Phase 2 clinical trial update evaluating green tea catechins for men with prostate cancer on active surveillance; the study is currently a…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer [Phase 2]
A Phase 2 trial evaluating a combination of apalutamide, abiraterone acetate, and prednisone in metastatic castration-resistant prostate can…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer [Phase 2]
This Phase 2 clinical trial evaluates enzalutamide combined with relacorilant versus placebo for patients with high-risk localized prostate …
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer [Phase 3]
A Phase 3 study evaluating Copper-64 PSMA I&T PET imaging for men with suspected recurrence of prostate cancer has completed, sponsored by C…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC) [Phase 2]
This entry covers a Phase 2 clinical trial evaluating Bipolar Androgen Therapy (BAT) in combination with Radium-223 for metastatic castratio…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer [Phase 2]
A Phase 2 trial of Erdafitinib in castration-resistant prostate cancer was terminated; the document provides the status update without repor…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating BL-B01D1 in patients with metastatic or unresectable non-small cell lung cancer and other solid tumors is …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of vorinostat and Lutetium-177 PSMA-617 for PSMA-low metastatic castration-resistant pro…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Strategic Endocrine Therapy and Targeted Radiotherapy for Prostate Cancer [Phase 2]
This is a Phase 2 clinical trial update examining strategic endocrine therapy with targeted radiotherapy for prostate cancer. The study stat…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors [Phase 2]
This phase 2 trial update investigates nivolumab with docetaxel and androgen deprivation therapy in men with hormone-sensitive or metastatic…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS [Phase 1, Phase 2]
A clinical trial update for AS1986NS describing a single-arm, blinded fluorescent PSMA histopathology study in prostate cancer across Phase …
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Feasibility of Patient-Centered Home Care (PCHC) to Reduce Disparities in High-Risk Black Men (BM) With Prostate Cancer (CaP)
A Mayo Clinic-sponsored clinical trial update reports on the feasibility of a patient-centered home care model to reduce disparities among h…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery [Phase 2, Phase 3]
Clinical trial update describing Phase 2/3 evaluation of antiandrogen therapy with radiation, with or without the chemotherapy drug docetaxe…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study [NA]
Pilot trial evaluating a diet and physical activity intervention to prevent ADT-induced metabolic changes in men with prostate cancer; the s…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC [Phase 3]
A Phase 3 study evaluating cabozantinib in combination with atezolizumab versus a second hormonal therapy in metastatic castration-resistant…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Utility of Adding MR Fusion to Standard US Guided Prostate Biopsy
A clinical trial evaluating adding MR fusion to standard ultrasound-guided prostate biopsy is suspended, indicating halted study activity.